Xconomy’s Digital Events →
There are plenty of smart executives in the world, but they often make poor leaders. That’s because it takes both intelligence and maturity to excel at leadership. And when I say... Read more »
In any business, projects fail, but in biopharmaceuticals, the consequences of failure are especially damaging. Projects in the industry tend to be long and expensive—from clinical trials to regulatory approvals to... Read more »
Sponsored · Video
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.